Molecular biological characterization of phosphodiesterase 3A from human corpus cavernosum

Chemico-Biological Interactions

Volumn 119-120, Issue , 1999, Pages 593-598

  Küthe, Andrea ^a,b   Eckel, Heike ^a,b   Stief, Christian G ^a   Ückert, Stefan ^a   Forssmann, Wolf G ^b   Jonas, Udo ^a   Mägert, Hans J ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b IPF PHARMACEUTICALS GMBH   (Germany)

Author keywords

Corpus cavernosum penis; Erectile dysfunction; PDE; Phosphodiesterase

Indexed keywords

CYCLIC AMP; CYCLIC GMP; ISOENZYME; PHOSPHODIESTERASE; PHOSPHODIESTERASE 3A; UNCLASSIFIED DRUG;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS CAVERNOSUM; DNA SEQUENCE; ERECTILE DYSFUNCTION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HUMANS; IMPOTENCE; ISOENZYMES; MALE; MUSCLE, SMOOTH; MYOCARDIUM; ORGAN SPECIFICITY; PENIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0344223272     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00074-5     Document Type: Conference Paper

References (18)

1. Beavo J.A., Reifsnyder D.H. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmac. Sci. 11:1990;150-155.
2. Bentley J.K., Beavo J.A. Regulation and function of cyclic nucleotides. Curr. Opin. Cell. Biol. 4:1992;233-240.
3. Hall I.P. Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses. Br. J. Clin. Pharmac. 35:1993;1-7.
4. Burns F., Zhao A.Z., Beavo J.A. Cyclic nucleotide phosphodiesterases: gene complexity, regulation by phosphorylation, and physiological implications. Adv. Pharmacol. 36:1996;29-48.
5. Taher A., Meyer M., Schulz-Knappe P., Forssmann W.G., Stief C.G., Jonas U. Phosphodiesterase activity in human cavernous tissue and the effect of various selective inhibitors. J. Urol. (abstract). 149:1993;285.
6. Ückert S., Stief C.G., Becker A.J., Truss M.C., Djamilian M., Thon W.F., Jonas U. The effect of the specific phosphodiesterase (PDE) III-inhibitor milrinone on human and rabbit cavernous tissue in vitro and in vivo. J. Urol. (abstract). 151:1994;495.
7. Stief C.G., Taher A., Truß M., Ückert S., Meyer M., Schultz-Knappe P., Forssmann W.G., Jonas U. Die Phosphodiesterase-Isoenzyme des humanen Corpus cavernosum penis und deren funktionelle Bedeutung. Akt. Urol. 26:1995;22-24.
8. Boolell M., Allen M. J., Ballard S. A., Gepi-Attee S., Muirhead G. J., Naylor A. M., Osterloh I. H., Gingell C. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int. J. Impot. Res. 8:1997;47-52.
9. Meacci E., Taira M., Moos J.R.M., Smith C.J., Movesesian A., Degermann E., Belfrage P., Manganiello V. Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase. Proc. Natl. Acad. Sci. USA. 89:1992;3721-3725.
10. Stoclet J.-C., Keravis T., Komas N., Lugnier C. Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiovascular diseases. Exp. Opin. Invest. Drugs. 4:1995;1081-1100.
11. Manganiello V.C., Taira M., Degermann E., Belfrage P. Type III cGMP-inhibited cyclic nucleotide phosphodiesterases. Cell. Signalling. 1:1995;445-455.
12. Cheung P.P., Xu H., McLaughlin M.M., Ghazaleh F.A., Livi G.P., Colman R.W. Human platelet cGI-PDE: expression in yeast and localization of the catalytic domain by deletion mutagenesis. Blood. 88:1996;1321-1329.
13. Tang K.M., Jang E.K., Haslam R.J. Expression and mutagenesis of the catalytic domain of cGNP-inhibited phosphodiesterase (PDE3) cloned from human platelets. Biochem. J. 323:1997;217-224.
14. Miki T., Taira M., Hockman S., Shimada F., Lieman J., Napolitano M., Ward D., Taira M., Makino H., Manganiello V.C. Characterization of the cDNA and gene encoding human PDE3B, the cGIP1 isoform of the human cyclic GMP-inhibited cyclic nucleotide phosphodiesterase family. Genomics. 36(3):1996;476-485.
15. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
16. Nishimura A., Morita M., Nishimura Y., Sugino Y. A rapid and highly efficient method for preparation of competent Escherichia coli cells. Nucleic Acids Res. 18:1990;6169.
17. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
18. Bourguignon J.J., Desaubry P.R., Wermuth C.G., Lugnier C. 9-Benzyladenines: Potent and selective cAMP phosphodiesterase inhibitors. J. Med. Chem. 40:1997;1768-1770.